| |
Renal safety of atazanavir-based regimens in human immunodeficiency virus (HIV) infected patients
|
| |
| |
Reported by Jules Levin
15th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV · October 15-17, 2010 · Brussels, Belgium
Sandrine Cure1, Florence Bianic2, Caroline Espinas2, Helene Hardy3, Lisa Rosenblatt3, Timothy Juday3 1OptumInsight, Uxbridge, UK; 2OptumInsight, Paris, France; and 3Bristol-Myers Squibb, Plainsboro, NJ, USA
|
|
| |
| |
|
|
|
